Author

Chika Sakai

An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells

2020 · Shogo Kumagai, Yosuke Togashi, et al. · Immunity · 264

PDF

Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids

2019 · Akihiro Tokunaga, Daisuke Sugiyama, et al. · The Journal of Experimental Medicine · 125

Mitochondrial Complex III Deficiency Caused by a HomozygousUQCRC2Mutation Presenting with Neonatal-Onset Recurrent Metabolic Decompensation

2012 · Noriko Miyake, Shoji Yano, et al. · Human Mutation · 92

Mitochondrial fumarate reductase as a target of chemotherapy: From parasites to cancer cells

2011 · Chika Sakai, Eriko Tomitsuka, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 92

A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55)

2012 · Haruo Shimazaki, Yoshihisa Takiyama, et al. · Journal of Medical Genetics · 87

ECHS1 Mutations Cause Combined Respiratory Chain Deficiency Resulting in Leigh Syndrome

2014 · Chika Sakai, Seiji Yamaguchi, et al. · Human Mutation · 69

PDF

Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions

2018 · Yukiko Miyazaki, Daniel K. Inaoka, et al. · Frontiers in Pharmacology · 57

PDF

IBA57 mutations abrogate iron-sulfur cluster assembly leading to cavitating leukoencephalopathy

2017 · Akihiko Ishiyama, Chika Sakai, et al. · Neurology Genetics · 40

PDF

Inhibition of Cancer Cell Growth by GRP78 siRNA Lipoplex via Activation of Unfolded Protein Response

2014 · Kazushi Matsumura, Chika Sakai, et al. · Biological and Pharmaceutical Bulletin · 20

PDF

Type II Fp of human mitochondrial respiratory complex II and its role in adaptation to hypoxia and nutrition-deprived conditions

2013 · Chika Sakai, Eriko Tomitsuka, et al. · Mitochondrion · 20

The Burden of Undiagnosed Adults With Attention-Deficit/Hyperactivity Disorder Symptoms in Japan: A Cross-Sectional Study

2021 · Noriyuki Naya, Toshinaga Tsuji, et al. · Cureus · 19

PDF

Homoplasmy of a mitochondrial 3697G>A mutation causes Leigh syndrome

2014 · Yutaka Negishi, Ayako Hattori, et al. · Journal of Human Genetics · 18

[Immunosuppressive Environment in Tumors].

2018 · Chika Sakai, Hiroyoshi Nishikawa · PubMed · 12

Efficacy and safety of guanfacine extended‐release in Japanese adults with attention‐deficit/hyperactivity disorder: Exploratory post hoc subgroup analyses of a randomized, double‐blind, placebo‐controlled study

2020 · Noriyuki Naya, Chika Sakai, et al. · Neuropsychopharmacology Reports · 9

PDF

Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan

2025 · Kazuhito Suzuki, Yuma Fujimori, et al. · Cancers · 6

PDF

Pharmacological properties and clinical effects of the ADHD drug, Lisdexamfetamine (Vyvanse® capsules 20 mg and 30 mg)

2020 · Chika Sakai · Folia Pharmacologica Japonica · 5

PDF

An exploratory study of factors associated with long-term, high-dose opioid prescription in cancer patients in Japan based on a medical claims database

2022 · Tatsuya Hashimoto, Hirokazu Mishima, et al. · Supportive Care in Cancer · 2

PDF

Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis

2021 · Chika Sakai, Toshinaga Tsuji, et al. · Neuropsychiatric Disease and Treatment · 2

PDF

Applying Artificial Intelligence Machine Learning to Discover Factors That Shorten Duration of Treatment in Patients with Multiple Myeloma Using Real-World Patient-Level Longitudinal Data from Medical Data Vision Database

2023 · Hiroshi Handa, Tadao Ishida, et al. · Blood · 1

Japanese subgroup analysis of AQUILA trial: daratumumab vs active monitoring in high-risk smoldering multiple myeloma

2026 · Kenshi Suzuki, Hiroshi Kosugi, et al. · Japanese Journal of Clinical Oncology

Daratumumab plus VRd in Japanese transplant-ineligible/deferred NDMM patients: Japanese subgroup of the CEPHEUS trial

2026 · Kenshi Suzuki, Morio Matsumoto, et al. · International Journal of Hematology

PDF

Assessment of Predictive Factors That Shorten Duration of Treatment in Patients With Multiple Myeloma Using AI: Real-World Longitudinal Study Using Data From Medical Data Vision Claims Database

2025 · Hiroshi Handa, Tadao Ishida, et al. · JMIR Cancer

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan

2025 · Kazuhito Suzuki, Miku Ito, et al. · Current Medical Research and Opinion

PDF

1P115 Fast thermal denaturation of the hyperthermophilic protein, ST1625 product(3. Protein folding and misfolding (1),Poster Session,Abstract,Meeting Program of EABS & BSJ 2006)

2006 · Shuichiro Goda, Chihiro Morimoto, et al. · Seibutsu Butsuri

PDF

Works count: 24

Citation count: 940

H-index: 12

I10-index: 13